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Nerve Tissue-Specific Human Glutamate Dehydrogenase
that Is Thermolabile and Highly Regulated by ADP
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mate to a-ketoglutarate, is expressed at high levels in
mammalian brain (Smith et al., 1975). Although the
exact function of GDH in brain is not fully understood,
the enzyme is enriched in glutamatergic receptive regions (Aoki et al., 1987), where it is highly concentrated in astrocytes ( 10 mg of GDH protein/ml of mitochondrial matrix) (Rothe et al., 1994). These observations are consistent with a suggested role for this
enzyme in the metabolism of synaptic glutamate
(Plaitakis et al., 1984; Colon et al., 1986).
At present, the functional significance of GDH in
nerve tissue remains uncertain. Although thermodynamically the GDH reaction favors glutamate synthesis, aspartate aminotransferase may be more important
than GDH in forming glutamate from a-ketoglutarate
in vivo (Palaiologos et al., 1988; Christensen et al.,
1991). Cooper et al. ( 1979) previously showed that
13
NH3 ammonia given systemically to rats failed to
incorporate into brain glutamate, thus suggesting that
GDH is not functioning toward the synthesis of this
amino acid in nerve tissue. On the other hand, Yu et
al. ( 1982) suggested that GDH may play a role in
glutamate oxidation in astrocytes. Also, Erecinska and
Nelson ( 1990) found that activation of GDH activity
increased the rate of glutamate oxidation by rat brain
synaptosomes. Other studies (Kuo et al., 1994) have
also suggested that, in spite of the high GDH concentration in brain, the metabolic flux through this pathway is quite low in vivo, thus inferring that enzyme
activity is regulated. Kuo et al. ( 1994) further suggested that, in rat brain, this is due to the inhibitory
effect of magnesium and polyamines on GDH activity .
Previous studies have shown that GDH activity is
reduced in leukocytes and ~broblasts of patients with

Abstract: Glutamate dehydrogenase (GDH), an enzyme
that is central to the metabolism of glutamate, is present
at high levels in the mammalian brain. Studies on human
leukocytes and rat brain suggested the presence of two
GDH activities differing in thermal stability and allosteric
regulation, but molecular biological investigations led to
the cloning of two human GDH-specific genes encoding
highly homologous polypeptides. The first gene, designated GLUD1, is expressed in all tissues (housekeeping
GDH), whereas the second gene, designated GLUD2, is
expressed specifically in neural and testicular tissues. In
this study, we obtained both GDH isoenzymes in pure
form by expressing a GLUD1 eDNA and a GLUD2 eDNA
in Sf9 cells and studied their properties. The enzymes
generated showed comparable catalytic properties when
fully activated by 1 mM ADP. However, in the absence
of ADP, the nerve tissue-specific GDH showed only 5%
of its maximal activity, compared with ,....,40% showed by
the housekeeping enzyme. Low physiological levels of
ADP (0.05-0.25 mM) induced a concentration-dependent enhancement of enzyme activity that was proportionally greater for the nerve tissue GDH (by 5501,300%) than of the housekeeping enzyme {by 120150%). Magnesium chloride (1-2 mM) inhibited the
nonactivated housekeeping GDH (by 45-64%); this inhibition was reversed almost completely by ADP. In contrast, Mg 2 + did not affect the nonstimulated nerve tissuespecific GDH, although the cation prevented much of the
allosteric activation of the enzyme at low ADP levels
(0.05-0.25 mM). Heat-inactivation experiments revealed
that the half-life of the housekeeping and nerve tissuespecific GDH was 3.5 and 0.5 h, respectively. Hence, the
nerve tissue-specific GDH is relatively thermolabile and
has evolved into a highly regulated enzyme. These allosteric properties may be of importance for regulating
brain glutamate fluxes in vivo under changing energy demands. Key Words: Glutamate dehydrogenase- Human
brain-Glutamate metabolism-ADP enzyme regulation- Enzyme thermolability.
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Glutamate dehydrogenase ( GDH), the enzyme that
catalyzes the reversible oxidative deamination of gluta-
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retically distinct isoproteins. More recent studies have
shown that two different GDH isoproteins are also
present in bovine brain ( Cho et al., 1995).
Molecular biological studies (Mavrothalassitis et al.,
1988; Shashidharan et al., 1994) revealed that multiple
GDH-specific genes are present in the human. At least
two of these genes are functional. The first, designated
GLUD 1, is an intron-containing gene mapping to human chromosome 10; the mRNA of this gene is expressed in all tissues (housekeeping) (Hanauer et al.,
1987; Mavrothalassitis et al., 1988; Anagnou et al.,
1993; Michaelidis et al., 1993) and is the only GDHspecific message found in human liver ( Shashidharan
et al., 1994). The second, designated GLUD2, is encoded by an X-linked intronless gene, the mRNA of
which is specifically expressed in neural and testicular
tissues ( Shashidharan et al., 1994) .
The polypeptides predicted by the two genes share
a 96% amino acid sequence homology ( Shashidharan
et al., 1994), with this similarity in structure probably
accounting for the inability to separate them in a clean
form from human tissues. The availability of recombinant DNA technology has permitted us now to obtain
and study each of these human GDH isoenzymes in
pure (unmixed), catalytically active forms by expressing the corresponding cDN As in the insect Spodoptera
frugiperda ( Sf9) cells. Results revealed that the nerve
tissue-specific isoform has evolved into a highly regulated enzyme that is markedly activated by ADP at
concentrations that can occur when cellular energy
charge declines.
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FIG. 1. Expression of GLUD1 (housekeeping) and GLUD2
(nerve tissue-specific) eDNA in Sf9 cells. A: PCR amplification
of a 580-bp DNA segment using DNA isolated from Sf9 cell
cultures infected with recombinant baculovirus containing the
human GLUD1 eDNA (G1; lane 1) or GLUD2 eDNA (G2; lane
1 ). Cloned human GLUD1 eDNA (G1; lane 2) and GLUD2 eDNA
(G2; lane 2) were used as controls. B: Restriction digestion of
amplified DNA with Sa/1. Amplified DNA from human GLUD2
eDNA ( G2) generates two smaller fragments (cleaved), whereas
that from human GLUD2 eDNA (G1) remains uncleaved (uncut).

multisystemic neurological disorders that are clinically
and pathologically heterogeneous (Plaitakis et al.,
1980, 1982; Duvoisin et al., 1983, 1988; Aubby et al.,
1988; Abe et al., 1992). Our work with neurologic
patients led to the finding that GDH is present in human
tissues in "heat-labile" and "heat-stable" forms and
that, in these patients, reduction in GDH activity was
largely limited to the heat-labile component (Plaitakis
et al., 1984) . Similar results have been obtained by
other (Konagaya et al., 1986; Kajiyama et al., 1988;
lwattsuji et al., 1989; Abe et al., 1992) but not all
(Aubby et al., 1988; Duvoisin et al., 1988) investigators. Additional studies in our laboratory (Colon et al.,
1986) showed the presence of two GDH activities in
rat brain differing in their relative resistance to thermal
inactivation, detergent extractability, and allosteric
regulation characteristics. Further investigations at the
protein level (Hussain et al., 1989) revealed that GDH
purified from human brain consists of four electropho-
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FIG. 2. N-terminal amino acid se-
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quence of human recombinant
GLUD1 and GLU02-derived GDHs.
The expressed proteins were blotted
onto polyvinylidene difluoride membranes, and their N-terminus was
sequenced (amino acids shown in
boldface). The leader peptide sequence is shown in italics. The predicted amino acids that are different
in the two cDNAs are circled. The
cleavage site of the leader peptide
is indicated by an arrow. In the Nterminus of the mature (processed)
protein, an alanine to leucine transition was detected at the third amino
acid position; this is predicted by the
corresponding cDNAs (Shashidharan et al., 1994).

Arg
Gly

MATERIALS AND METHODS
Materials
Sf9 cells and the baculovirus expression vectors were obtained from Invitrogen (San Diego; CA; U.S.A.). Insect cell
media and fetal calf serum were obtained from Life Technol-
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Enzyme assay
GDH was assayed spectrophotometrically in the direction
of reductive amination of a-ketoglutarate. For this, the reaction mixture of 1 ml contained 50 mM triethanolamine buffer
(pH 8.0, except as indicated), 100 mM ammonium acetate,
150 J.LM NADPH, and 2.6 mM EDTA. ADP was also added
to 1 mM unless otherwise specified. The reaction was started
with addition of a-ketoglutarate to 8 mM (Colon et al.,
1986).
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FIG. 3. Thermal stability of recombinant human GDHs.
Housekeeping (GLUD1-derived GDH; e) and nerve tissue-specific (GLUD2-derived GDH; •) GDHs were obtained by expression of the corresponding cDNAs in Sf9 cells as described in
Materials and Methods. The enzyme extracts were mixed with
1:1 (vol/vol) bovine serum albumin (8 mg/ml) in 100 mM (pH
7.4) phosphate buffer. The enzyme mixture was incubated at
45.5°C in Eppendorf tubes. Aliquots were removed at specified
intervals and assayed at pH 8.0 in the presence of 1 .0 m M ADP
as described in Materials and Methods. Data are mean + SEM
(bars) values of three determinations. Baseline activity refers to
enzyme activity at 0 min of incubation.

ogies (Bethesda, MD, U.S.A.). Modified baculovirus (BaculoGold) was from Pharmingen (San Diego, CA, U.S.A.).
NADH, NADPH, a-ketoglutaric acid, ADP, GTP (lithium
salt), and bovine liver GDH were from Boehringer Mannheim Biochemicals (Indianapolis, IN, U.S.A.) . Spermine
and MgCh were from Sigma Chemical (St. Louis, MO,
U.S.A.). Materials for polyacrylamide gel electrophoresis
were from Bio-Rad (Richmond, CA, U.S.A.), and polyvinylidene difluoride membranes were from Millipore (Bedford,
MA, U.S.A.).

Expression of GLUDJ and GLUD2 eDNA in
Sf9 Cells
A GLUDJ eDNA and a GLUD2 eDNA derived from human liver and retina mRNA, respectively, were expressed
in the baculovirus expression system. The coding region of
each of these cDNAs was PCR-amplified (Shashidharan et
al., 1994). The products obtained were subcloned, ligated
to the baculovirus transfer vector (pVL 1392; Invitrogen),
and used to transform Escherichia coli (INValphaF'). The
proper orientation of the insert was verified by DNA sequencing. Sf9 cells were cotransfected with the plasmid
DNA and modified baculovirus DNA (BaculoGold; Pharmingen) and were incubated at 27°C for 4 days. The recombinant virus was amplified with two additional rounds of
infection. Sf9 cells were harvested and homogenized in a
buffer containing 0.05 M Tris-HCl (pH 7.4) , 1% Triton X100, 0.1 mM phenylmethylsulfonyl fluoride, and 0.5 M
N aCl. The extracts obtained were used for enzyme assays,
kinetic analyses, thermal inactivation, and immunoblotting,
as described above. The protein concentrations were determined as previously described (Lowry et al., 1951).
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Stimulation of GDH activity by ADP was carried out by
adding increasing amounts of ADP (final concentration,
0.05-1.0 mM) to the above assay mixture. Similar ADP
stimulation studies were also carried out at different pH
values using 0.1 M phosphate buffer (pH 6.5, 7 .0, 7 .5, or
8.0). The effects of spermine and Mg 2 + on GDH activity
were determined by adding either compound to the reaction mixture (final concentration, 1-2 mM) with or without ADP.

Heat inactivation of recombinant GDHs
Sf9 cell extracts containing expressed GLUD1- or
GLUD2-derived protein were mixed ( 1:1) with 100 mM
sodium phosphate buffer (pH 7.4) containing 8 mg/ml bovine serum albumin. The samples were incubated at 45.0°C
in a shaking water bath; aliquots were removed at specific
intervals and assayed immediately as described above with
the addition of 1.0 mM ADP (final concentration) to the
reaction mixture.

Purification and N-terminal amino acid
sequencing of recombinant GDHs
Both recombinant human GDHs were partially purified
from Sf9 cell extracts according to a previously described
method (Hussain et al., 1989), and the amino acid sequence
of their N-terminus was determined. In brief, the purification
method involves ammonium sulfate fractionation and hydrophobic interaction chromatography. A 30-65% ammonium sulfate cut of a high-speed ( 100,000 g for 1 h) supernatant of these extracts was obtained and dissolved in TrisHCI buffer (0.05 M, pH 6.0) containing ammonium sulfate
to 15% saturation. It was then loaded onto a column ( 1.5
X 30 em) packed with pheny1-Sepharose-4B and equilibrated with the same buffer. The column was washed with
200 ml of equilibration buffer (to remove any nonspecifically bound proteins) and eluted with a total of 250 ml of
a double linear gradient of 0-90% ethylene glycol and 150o/o ammonium sulfate. Fractions containing GDH activity
were pooled, dialyzed against deionized distilled water, and
loaded on a discontinuous 5-15% linear gradient polyacrylamide gel containing 0.1 % sodium dodecyl sulfate as previously described (Hussain et al., 1989). The proteins were
transferred to a polyvinylidene difluoride membrane according to the method of Matsudaira ( 1987) using 250 mA
constant current for 4 h in a Bio-Rad electroblotting apparatus. The electroblotted polyvinylidene difluoride membrane
was washed in deionized distilled water for 5 min, stained
with 0.1 % Coomassie Brilliant Blue R250 in 50% methanol
for 30 s, and then destained for 3- 5 min in 50% methanol/
10% acetic acid. It was finally rinsed in deionized distilled
water and air-dried. The GDH band was cut out and used
for N-terminal amino acid sequencing ( Matsudaira, 1987).
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FIG. 4. Allosteric regulation of recombinant human GDHs by ADP.
Enzyme assays of housekeeping
(GLUD1-derived GDH) and nerve tissue-specific (GLU02-derived GDH)
GDH were performed using triethanolamine buffer (pH 8.0) in the presence of increasing concentrations of
ADP (0.01-1.0 mM). Baseline activity was determined in the absence of
ADP ( 100%). Data are mean + SEM
(bars) values from three determinations. GDH activity was measured in
the direction of reductive amination
of a-ketoglutarate as described in
Materials and Methods.
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Statistical analysis
2

The significance of the effect of Mg + on recombinant
human GDH activities was analyzed by an unpaired twotailed t test. The statistical analysis was carried out using
Microsoft Excel version 4.0 software. The Hill plot coefficient and the cooperativity index were calculated using Enzfitter software (Elsevier-BIOSOFf, Cambridge, U.K.).

RESULTS
Production of recombinant human GDHs
The specific multiplication of recombinant baculovirus containing either the GLUD 1 or the GLUD2 eDNA
in the Sf9 cell cultures infected by the recombinant
viruses was verified by Sall digestion of a PCR-amplified DNA segment containing a Sall restriction site
unique to the GLUD2 eDNA ( Shashidharan et al.,
1994) . As shown in Fig. 1, this treatment resulted in
complete cleavage of the GLUD2 eDNA-derived PCR
product, but it left uncut the GLUDJ eDNA-derived
DNA segment. Immunoblots of Sf9 cell extracts using
anti-GDH antiserum (Shashidharan et al., 1994) revealed that cells infected with both recombinant baculoviruses showed GDH-positive immunoreactivity, the
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density of which increased between day 2 to 5 postinfection (data not shown) .
Sequencing of the N-terminus of the recombinant
proteins revealed that both the GLUD1 - and GLUD2generated polypeptides had been processed within the
host cells in a manner similar to that occurring for
the mature mammalian GDH, which involves removal
of the leader peptide (Fig. 2) . Moreover, these sequencing data confirmed the presence of leucine and
alanine at position 3 for the nerve tissue-specific
( GLUD2-derived) and the housekeeping ( GLUDJderived) GDH, respectively, as predicted by the corresponding cDNAs (Fig. 2), thus verifying the specific expression of the cDNAs in the corresponding
cell lines.

Thermal stability characteristics of GLUD 1- and
GLUD2-generated GDH
Heat-inactivation studies revealed that the two recombinant proteins differed in their relative resistance
to thermal denaturation. At 45°C (pH 7.4), heat inactivation proceeded faster for the nerve tissue-specific
GDH (half-life = 0.5 h) than for the housekeeping
enzyme (half-life = 3.5 h), as shown in Fig. 3.
J. Neurochem., Vol. 68, No. 5, 1997
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FIG. 5. Effect of pH on the activation of recombinant
GDHs by ADP. Enzyme assays were performed at
various pH values in the absence or the presence of
increasing concentrations of ADP. Phosphate buffer
(0.1 M) was used instead of triethanolamine buffer
for this set of experiments. Data are mean + SEM
(bars) values from three determinations. GDH activity
was measured in the direction of reductive amination
of a-ketoglutarate as described in Materials and
Methods. The percentage of activation by ADP at pH
8.0 (data not shown) was similar to that presented
in Fig. 4.
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Regulation of recombinant GDH activities
by ADP
Enzyme assays of Sf9 cell extracts revealed that
expression of the GLUD1 or GLUD2 in these cells
generated proteins capable of catalyzing the reversible
interconversion of glutamate to a-ketoglutarate in the
presence of either NAD(H) or NADP(H). Because
the insect GDH shows an absolute specificity for
NAD(H) (Shashidharan et al., 1994) and the human
GDH is capable of using both cofactors (Plaitakis et
al., 1980), measurement of enzyme activity in the presence of NADP(H) provided a simple way of eliminating all background activity.
The specific activities of the two recombinant human
GDHs were similar when analyzed in the presence
of 1 mM ADP. However, the two enzymes differed
markedly in their ability to interconvert glutamate to aketoglutarate when assayed in the absence of allosteric
effectors; the nerve tissue-specific GDH was largely
inactive, whereas the housekeeping enzyme showed
about half of its maximal specific activity (Fig. 4).
ADP at 0.05-0.25 mM induced a proportionally
greater degree of stimulation for the nerve tissue-specific than for the housekeeping enzyme. This differential effect increased at higher nucleotide concentrations
(0.5-1.0 mM), with 1.0 mM ADP stimulating the
J. Neurochem., Vol. 68, No. 5, 1997
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nerve tissue-specific GDH to '""2,000% of baseline activity while inducing only a 2.5-fold activation of the
housekeeping enzyme (Fig. 4).

Effect of pH on ADP activation of recombinant
human GDHs
Enzyme assays, performed at various pHs, revealed
that the nonstimulated activity (baseline) of the
GLUDJ-derived GDH (housekeeping) increased by
about fourfold as the pH of the reaction buffer increased from 6.5 to 8.0 (Fig. 5); however, the ADP
activation of the GLUDJ isoenzyme remained proportionally the same (200-250% of baseline activity; Fig.
5). In contrast, whereas the baseline activity of the
GLUD2-derived GDH (nerve tissue-specific) was unaffected by varying the pH of the reaction buffer, the
ADP activation of this isoenzyme was enhanced with
increasing pH; addition of0.5 mM ADP (final concentration) at pH 6.5, 7.0, 7.5, and 8.0 increased the activity of the GLUD2-derived GDH to 600, 700, 1,238,
and 2,100% of baseline activity, respectively (Fig. 5).
Hence, increasing the pH of the reaction buffer between 6.5 and 8.0 enhances the nonstimulated (baseline) activity of the housekeeping GDH, whereas it
renders the nerve tissue-specific isoenzyme increasingly sensitive to allosteric activation by ADP.
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Effect of magnesium chloride on recombinant
human GDHs
In the absence of ADP, magnesium chloride ( 1.0
and 2.0 mM) inhibited the housekeeping GDH (by 45
and 64%, respectively), but it had no effect on the
nonstimulated nerve tissue-specific enzyme (Fig. 6).
In the presence of low physiological concentrations of
ADP (0.05-0.25 mM), however, this inhibitory effect
of magnesium chloride was completely abolished (Fig.
7). Magnesium had little effect on the baseline activity
of the nerve tissue-specific GDH, but it modified its
allosteric regulation by preventing most of the activation of this enzyme at 0.05-0.25 but not at 1.0 mM
concentrations of ADP. As a result, the hyperbolic
ADP activation curve became sigmoidal in the presence of magnesium chloride (Fig. 6). This change was
significant by Hill plot analysis, which showed that the
Hill plot coefficient for ADP stimulation was 1.24 +
0.02 in the absence of magnesium chloride and 1.81
+ 0.04 (p < 0.001) in the presence of the cation.
Spermine, shown to be inhibitory to rat brain GDH
(Kuo et al., 1994), had no effect on either human
GDH isoenzyme (data not shown).
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FIG. 7. Effect of magnesium chloride on ADP activation of recombinant human GDHs. GLU02-derived GDH was assayed in
the absence (0 ) or in the presence of 2.0 mM Mg 2 + (D ); GLU01derived GDH was also assayed in the absence (6 ) or in the
presence of 2.0 mM Mg 2 + (\7 ). Allosteric activation of the recombinant human isoenzymes was studied by varying ADP levels
from 0 to 1,000 p,M while keeping the concentration of the other
substrates constant. Data are mean + SEM (bars) values of
three determinations.

DISCUSSION
In this study, we evaluated the thermal stability and
allosteric regulation characteristics of recombinant human GDH isoproteins generated by expression of
GLUDJ (housekeeping) and GLUD2 (nerve tissuespecific) cDNAs in Sf9 cells. Results revealed that the
housekeeping GDH is relatively heat-stable, whereas
the nerve tissue-specific enzyme is relatively heat-labile. Because activity of the heat-labile GDH is selectively reduced in some patients with multisystem degeneration, these results suggest a selective defect in
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FIG. 6. Effect of magnesium chloride on nonactivated recombinant human GDHs. Enzyme assays were performed using recombinant human housekeeping (GLUD1) or nerve tissue-specific (GLUD2) GDH isoenzymes in either the absence (open columns) or presence (hatched columns) of 1.0 or 2.0 mM
magnesium chloride. Data are average + SEM (bars) values of
three determinations. *p < 0.02, ** p < 0.001.

the nerve tissue-specific GDH in these patients. This
remains to be tested in future studies.
Evaluation of the regulatory properties of the two
expressed GDH isoproteins revealed that the nerve tissue-specific GDH has evolved into a highly regulated
enzyme showing little catalytic activity when assayed
in the absence of allosteric effectors but being markedly activated (up to 1,300%) by relatively low physiological concentrations of ADP ( 0.02- 0.25 mM). In
contrast, the housekeeping GD H depends much less
on ADP for its activation, maintaining ---50% of its
maximal activity in the absence of this nucleotide.
Varying the pH of the reaction buffer had a differential effect on the allosteric regulation of the two isoenzymes by ADP. When the pH increased between 6.5
and 8.0, the nonstimulated (baseline) activity of the
housekeeping GDH was enhanced, although the proportional activation of this isoenzyme by ADP was not
altered. In contrast, increasing the pH between 6.5 and
8.0 markedly enhanced the ADP activation of the nerve
tissue-specific GDH without affecting its baseline specific activity. Bailey et al. ( 1982) previously reported
that ADP is inhibitory to bovine liver GDH when the
reaction is carried at pH 6.5 and below. In the present
studies, we found that ADP had no inhibitory effect
on either human GDH isoenzyme at pH 6.5. Similar
results have been reported by Cho et al. ( 1995) using
bovine brain GDHs.
In addition, regulation of enzyme activity by magnesium was distinct for the two isoenzymes. The
housekeeping GDH was inhibited substantially by 1.0
or 2.0 mM magnesium chloride when assayed in the
absence of allosteric effectors, but this inhibition was
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largely reversed by low physiological concentrations
(0.05-0.25 mM) of ADP. Whereas magnesium had
little effect on the baseline activity of the nerve tissuespecific GDH, it modified its allosteric regulation by
preventing most of the activation of this enzyme at
0.05-0.25 but not at 1.0 mM ADP.
Magnesium levels in the mitochondrial matrix are
known to be in the range of 1.0 mM (Taylor et al.,
1991 ), but ADP levels can vary from 0.05 to> 1.0 mM
(depending on the rate of oxidative phosphorylation)
(Gabriel et al., 1986). Hence, results of this study
indicate that physiological levels of ADP and magnesium are capable of allosterically regulating human
nerve tissue-specific GDH. In particular, magnesium
is capable of shifting the relatively hyperbolic ADP
stimulation curve to one that is clearly sigmoidal. As
such, magnesium may play a role in keeping the nerve
tissue-specific GDH idle at low physiological concentrations of ADP (high rate of phosphorylation), while
permitting activation of this enzyme by higher concentrations of this nucleotide (low rate of phosphory lation).
When fully activated by ADP, the specific activity
of GDH purified from human brain is ""'160 p,mol of
glutamate/mg of protein/min (Hussain et al., 1989) .
Because the level of GDH in cerebellum is ""'10 mg/
ml of mitochondrial matrix (Rothe et al., 1994), this
represents a capacity for interconverting 1,600 p,mol
of glutamate/min/ml of mitochondria matrix or 160
p,mol of glutamate/min/ml of astrocytic volume ( mitochondria account for ""'1 0% of a cellular mass) . When
intracellular glutamate levels are low, unregulated high
GDH function could deplete a-ketoglutarate with resultant impairment of the tricarboxylic acid cycle and
other reactions that depend on this ketoacid. It is possible that the ability of the nerve tissue-specific GDH
to remain relatively inactive at low ADP levels may
represent an adaptation that permits the enzyme to attain high levels in astrocytes without interfering with
metabolic homeostasis of these cells.
In light of the present findings, the variable GDH
flux rates found in cultured astrocytes by several investigators (Yu et al., 1984; Erecinska and Nelson, 1990;
Yudkoff et al., 1991; Farinelli and Nicklas, 1992) may
relate to the state of GDH activation. Also, the present
data suggest that under conditions of increased hydrolysis of ATP to ADP, GDH function may be enhanced,
leading to increased oxidation or synthesis of glutamate by glial cells. With respect to the latter, the role
of GDH in brain glutamate formation remains controversial, particularly given the fact that the Km for ammonia is relatively high for this enzyme ( ""'12-20
mM) (Dennis et al., 1977; Colon et al., 1986). It remains to be further studied whether these enzyme properties are essential for the regulation of glutamate metabolism under changing energy demands and whether
this enzyme plays a role in protecting neurons against
excitotoxicity under conditions of enhanced glutamate
release and/ or energy failure.
J. Neurochem., Vol. 68, No. 5, 1997
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